Todd Sherer

Todd Sherer is the Chief Executive Officer of The Michael J. Fox Foundation for Parkinson’s Research (MJFF). Formally trained as a neuroscientist, Todd directs the organization’s research strategy and is responsible for the organization’s overall scientific and fundraising direction to speed treatment breakthroughs and a cure for Parkinson’s disease. Dr. Sherer has been a key architect of the Foundation’s strategy to define high-priority research areas for Parkinson’s disease — therapeutic targets and approaches that are closest or most critical to practical relevance in patients’ daily lives — in order to leverage donor-raised capital to push projects in these areas toward the clinic. He has played a major role in the Foundation’s efforts to increase the pharmaceutical industry’s investment in Parkinson’s disease drug development and engage the patient community to encourage and expand participation in clinical research. Today he is one of the world’s foremost experts on the science and business of Parkinson’s drug development, speaking frequently on these topics at conferences, to the media and to members of the Parkinson’s community. Dr. Sherer is also member of the Board of Directors of the Parkinson’s Action Network and participates in the Institute of Medicine of the National Academies Forum on Neuroscience and Nervous System Disorders. He is a collaborating scientist for the Coalition Against Major Diseases (CAMD) and, a member of the Udall Centers Coordinating Committee, and a member of the CINAPS Advisory Committee at the National Institute for Neurodegenerative Disease and Stroke, National Institutes of Health. Dr. Sherer currently serves on the Advisory Council for the National Center for Advancing Translational Sciences (NCATS). During his career as a bench researcher, Dr. Sherer published over 30 peer-reviewed articles in peer-reviewed scientific journals. He earned his PhD in Neuroscience from the University of Virginia and holds a BS from Duke University. [+]